Penumbra Inc. logo

Penumbra Inc.

PEN | NYSE
Chart Builder DCF Calculator
$318.95
$0.00 (0.00%)
Nov 2, 2026, 9:30 AM ET · Market open

Company Profile

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Key Executives

Name Position
Adam Elsesser Co-Founder, Chairman & Chief Executive Officer
Maggie S. Yuen Chief Financial Officer
Pankaj Tiwari Executive Vice President & Chief Information Officer
Arani Bose Co-Founder & Director
Ben Sorci Executive Vice President of Operations
Ben Tompkins Executive Vice President of Development & Compliance
Jason Richard Mills Executive Vice President of Strategy
Jee Hamlyn-Harris Investor Relations Officer
Johanna Roberts Executive Vice President, General Counsel & Secretary
Lambert Shiu Chief Accounting Officer
Shruthi Narayan President

Latest SEC Filings

Date Type Title
Sep 17, 2026 4 Filing
Aug 19, 2026 4 Filing
Aug 13, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jul 30, 2026 10-Q Quarterly Report
Jul 30, 2026 8-K Current Report
Jun 22, 2026 8-K Current Report
May 29, 2026 SD Filing
May 21, 2026 4 Filing
May 07, 2026 425 Filing
May 07, 2026 8-K Current Report
View All SEC Filings ➞
Penumbra Inc.
Penumbra Inc. logo
Country United States
IPO Date Sep 18, 2015
Industry Medical - Devices
Sector Healthcare
Employees 4,700
CEO Adam Elsesser

Contact Details

One Penumbra Place Alameda, California 94502 United States

Stock Details

Ticker Symbol PEN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001321732
CUSIP Number 70975L107
ISIN Number US70975L1070
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.